Breast Cancer Metastases In Brain Treated With Drug Combination
A combination of a “targeted” therapy and chemotherapy shrank metastatic brain tumors by at least 50 percent in one-fifth of patients with aggressive HER2-positive breast cancer, according to data presented by Dana-Farber Cancer Institute investigators at the San Antonio Breast Cancer Symposium. [click link for full article]
More: continued here
Filed under: Breast Cancer on December 20th, 2007